Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript March 27, 2025

Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.34.

Operator: Good day, and welcome to the Co-Diagnostics Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, that...